#biotech

Whatever the future holds in store, we’ll make sure you are part of it

"Humanity Version 2.0 - The Clone Protocol Has Begun." www.technologyreview.com

BIOTECH · Quantum-Si delays its protein-reading device, cuts staff Quantum-Si is cutting a fifth of its staff and pushing its next protein-sequencing machine, Proteus, back to 2027. Read the full story →

An AI-founded startup just exited. EchoGene (biotech) raised 154,000 from 108 AI investors. Valuation at exit: 395,089. Founded, funded and sold entirely by AI agents. https://6ic.com/explore/startups (6ic.com)

$MDXH Explodes +125%! Q2 revenue $27.2M (+16% YoY) Sequential growth +$3.3M $20M capital raise closed Path to $110-115M full-year guidance Tissue business recovering hard @mdxhealth #MDXH #Biotech NOT FINANCIAL ADVICE. DYOR

Up and down the ladder: The latest comings and goings (statnews.com)

Up and Down the Ladder: Job Changes.. the latest comings and goings.. recognize anyone? statnews.com/pharmalot/20...

WIB-RTP: Women as Founders – Building, Funding, and Scaling Successful Life Science Ventures (community.womeninbio.org)

Interested in translating life sciences research into a startup? We are hosting a panel discussion on building, funding, and scaling biotechnology ventures. 🧪 👩‍🔬 📈 Register here by Sept. 2: 👇https://community.womeninbio.org/events/view/rtp91026

Stepping away from the day-to-day to celebrate the people behind our progress. Grateful for the dedication, creativity, and teamwork of the entire Remix team as we reach important milestones and advance our mission. Here’s to what we’ve accomplished and what’s ahead!

$ETON +35% premarket on strong Q2! Record revenue, margin expansion Raised full-year guidance Acquisitions of ASN-001 & IMPAVIDO HEMANGEOL relaunch beating expectations @EtonPharma #ETON #Earnings #Biotech NOT FINANCIAL ADVICE. DYOR

July's biopharma layoffs affect 466 employees, a 94% year-over-year drop (biospace.com)

July's biopharma layoffs affect 466 employees, a 94% year over year drop |

$CAPR +93% premarket! FDA agrees to review new Duchenne muscular dystrophy drug data Shares more than double on the news @CapricorInc #CAPR #FDA #Biotech NOT FINANCIAL ADVICE. DYOR

Be prepared for the unlimited potential that progress will deliver

Billionaire Home Depot cofounder Bernie Marcus’ foundation donates nearly $30 million toward stem cell research for heart attacks fortune.com

Xanadu and University of Alberta Explore Quantum Computing for Cancer Drug Discovery (thequantuminsider.com)

Xanadu is collaborating with the University of Alberta to apply photonic quantum computing to cancer research, simulating complex molecular interactions that challenge classical computational limits.

BIOTECH · Cullinan's lung cancer drug clears Phase 3 trial Zipalertinib, from Cullinan and Taiho, hit its goal in a trial for a hard-to-treat lung cancer, setting up a fight with J&J's Rybrevant. Read the full story →

Innovent Biologics and Daiichi Sankyo have entered an exclusive agreement to commercialize the FLT3 inhibitor Vanflyta in China for FLT3-ITD-positive leukemia patients. #Biotech #Pharma #Oncology #AML #Healthcare #LifeSciences #DaiichiSankyo Not financial advice. For educational purposes only.

Kane Biotech $KNE has engaged DNA Advisors to explore strategic alternatives, including partnerships, financings, acquisitions and other transactions. Disclaimer: Not financial advice. For informational purpose only

Formation Bio taps Biogen, Pfizer alum to tackle R&D’s ‘boring middle’ (pharmavoice.com)

Formation Bio taps Biogen, Pfizer asylum to ramble R&Ds 'boring middle' |

Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill (fiercebiotech.com)

Pfizer's former chemistry whizz debuts Khartis Therapeutics with $95M for thyroid eye disease pill |